Chinese expert consensus on hematologic malignancy karyotyping
- PMID: 40721192
- DOI: 10.1016/j.cca.2025.120507
Chinese expert consensus on hematologic malignancy karyotyping
Abstract
Chromosomal karyotype analysis is crucial for diagnosing and managing hematologic malignancies, yet inconsistent protocols compromise reliability. To standardize practices, this consensus integrates international guidelines (WHO, ICC, ELN) with clinical expertise, providing evidence-based recommendations for specimen collection, cell culture, chromosome harvesting, banding techniques, karyotype analysis, and reporting. By establishing uniform operational standards, this initiative seeks to mitigate variability, improve detection rates, and support precision medicine in hematologic malignancies.
Keywords: Chromosome; Chromosome banding; Cytogenetics; Hematologic malignancies; Karyotype analysis.
Copyright © 2025. Published by Elsevier B.V.
Conflict of interest statement
Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Publication types
MeSH terms
Supplementary concepts
LinkOut - more resources
Full Text Sources